SANGAMO THERAPEUTICS Trademark

Trademark Overview


On Monday, December 28, 2020, a trademark application was filed for SANGAMO THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SANGAMO THERAPEUTICS trademark a serial number of 90420060. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Friday, August 9, 2024. This trademark is owned by Sangamo Therapeutics, Inc.. The SANGAMO THERAPEUTICS trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Biochemicals, biologics, and pharmaceutical preparations, namely, reagents in the nature of engineered proteins for gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction, all for clinical medical use and medical use in the fields of human and animal therapeutics, diagnostics, bioinformatics, genetic diseases, gene therapy, and cell therapy; Reagents, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, CAR T-cell preparations, T-cell preparations, B-cell preparations, Treg preparations, and NK cell preparations, all for clinical medical use and medical use

Licensing of intellectual property rights

Biochemicals and biologics, namely, engineered proteins in raw material form for gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction, all for use in scientific research, medical pharmaceutical research, scientific agricultural biotechnology research, medical diagnostics research, industrial scientific biotechnology research and all for clinical medical laboratory use and medical laboratory use in the fields of human and animal therapeutics, diagnostics, bioinformatics, genetic diseases, gene therapy, and cell therapy; engineered proteins in raw material form for use in scientific research and analysis relating to genetic diseases, gene therapy, cell therapy, genome editing, and genome regulation; biochemicals and biologics, namely, reagents in the nature of engineered nucleic acids for laboratory use, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically ...

Medical and scientific research; technical scientific research and medical research consulting in the fields of bioinformatics and gene regulation, gene modification, and gene correction; product research and development of engineered proteins and nucleic acids for others; product design of genetic research tools and systems for others; custom product development of engineered proteins for use in gene editing
sangamo therapeutics

General Information


Serial Number90420060
Word MarkSANGAMO THERAPEUTICS
Filing DateMonday, December 28, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateFriday, August 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 28, 2021

Trademark Statements


Goods and ServicesBiochemicals, biologics, and pharmaceutical preparations, namely, reagents in the nature of engineered proteins for gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction, all for clinical medical use and medical use in the fields of human and animal therapeutics, diagnostics, bioinformatics, genetic diseases, gene therapy, and cell therapy; Reagents, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, CAR T-cell preparations, T-cell preparations, B-cell preparations, Treg preparations, and NK cell preparations, all for clinical medical use and medical use
Goods and ServicesLicensing of intellectual property rights
Goods and ServicesBiochemicals and biologics, namely, engineered proteins in raw material form for gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction, all for use in scientific research, medical pharmaceutical research, scientific agricultural biotechnology research, medical diagnostics research, industrial scientific biotechnology research and all for clinical medical laboratory use and medical laboratory use in the fields of human and animal therapeutics, diagnostics, bioinformatics, genetic diseases, gene therapy, and cell therapy; engineered proteins in raw material form for use in scientific research and analysis relating to genetic diseases, gene therapy, cell therapy, genome editing, and genome regulation; biochemicals and biologics, namely, reagents in the nature of engineered nucleic acids for laboratory use, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins in raw material form for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, CAR T-cell preparations, T-cell preparations, B-cell preparations, Treg preparations, and NK cell preparations, all for use in scientific research, analysis and diagnostics and all for medical clinical laboratory use and medical laboratory use
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesMedical and scientific research; technical scientific research and medical research consulting in the fields of bioinformatics and gene regulation, gene modification, and gene correction; product research and development of engineered proteins and nucleic acids for others; product design of genetic research tools and systems for others; custom product development of engineered proteins for use in gene editing

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, March 17, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 17, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 17, 2021
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSangamo Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRichmond, CA 94804

Party NameSangamo Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRichmond, CA 94804

Trademark Events


Event DateEvent Description
Thursday, December 31, 2020NEW APPLICATION ENTERED
Wednesday, June 30, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 24, 2021ASSIGNED TO EXAMINER
Wednesday, June 30, 2021NON-FINAL ACTION WRITTEN
Wednesday, June 30, 2021NON-FINAL ACTION E-MAILED
Monday, November 15, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 15, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 15, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 23, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 8, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 28, 2021PUBLISHED FOR OPPOSITION
Tuesday, December 28, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 22, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 22, 2022FAX RECEIVED
Monday, August 22, 2022SOU EXTENSION 1 FILED
Tuesday, August 23, 2022ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST
Monday, September 19, 2022RESPONSE TO ITU OFFICE ACTION ENTERED
Monday, September 19, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 26, 2022SOU EXTENSION 1 GRANTED
Tuesday, September 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 20, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, February 15, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 15, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 18, 2023SOU EXTENSION 3 GRANTED
Monday, February 20, 2023SOU EXTENSION 2 FILED
Monday, February 20, 2023SOU EXTENSION 2 GRANTED
Wednesday, February 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 18, 2023SOU TEAS EXTENSION RECEIVED
Friday, August 18, 2023SOU EXTENSION 3 FILED
Thursday, February 22, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 22, 2024SOU EXTENSION 4 FILED
Thursday, February 22, 2024SOU EXTENSION 4 GRANTED
Friday, February 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 9, 2024SOU TEAS EXTENSION RECEIVED
Friday, August 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 9, 2024SOU EXTENSION 5 GRANTED
Friday, August 9, 2024SOU EXTENSION 5 FILED